Advertisement

Highly Attenuated Vaccinia Virus Dis as a Potential Sars Vaccine

  • Koji Ishii
  • Hideki Hasegawa
  • Noriyo Nagata
  • Tetsuya Mizutani
  • Shigeru Morikawa
  • Masato Tashiro
  • Tetsuro Suzuki
  • Fumihiro Taguchi
  • Toshitada Takemori
  • Tatsuo Miyamura
  • Yasuko Tsunetsugu-Yokota
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 581)

Keywords

Severe Acute Respiratory Syndrome Infectious Bronchitis Virus Neutralize Activity Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Rota, P. A. , Oberste, M. S. , Monroe, S. S. , et al. , 2003, Characterization of a novel coronavirus associated with severe acute respiratory syndrome, Science 300:1394-1399.CrossRefPubMedGoogle Scholar
  2. 2.
    Marra, M. A. , Jones, S. J. , Astell, C. R. , et al. , 2003, The Genome sequence of the SARS-associated coronavirus, Science 300:1399-1404.CrossRefPubMedGoogle Scholar
  3. 3.
    Tagaya, I. , Kitamura, T. , and Sano, Y. , 1961, A new mutant of dermovaccinia virus, Nature 192:381-382.CrossRefPubMedGoogle Scholar
  4. 4.
    Ishii, K. , Ueda, Y. , Matsuo, K. , et al. , 2002, Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector, Virology 302:433-444.CrossRefPubMedGoogle Scholar
  5. 5.
    Ohnishi, K. , Sakaguchi, M. , Kaji, T. , et al. , 2005, Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies, Jpn. J. Infect. Dis. 58:88-94.PubMedGoogle Scholar
  6. 6.
    Mizutani, T. , Fukushi, S. , Saijo, M. , Kurane, I. , and Morikawa, S. , 2004, Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells, Biochem. Biophys. Res. Commun. 319:1228-1234.CrossRefPubMedGoogle Scholar
  7. 7.
    Weisz, O. A. , Swift, A. M. , and Machamer, C. E. , 1993, Oligomerization of a membrane protein correlates with its retention in the Golgi complex, J. Cell Biol. 122:1185-1196.CrossRefPubMedGoogle Scholar
  8. 8.
    Bisht, H. , Roberts, A. , Vogel, L. , et al. , 2004, Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice, Proc. Natl. Acad. Sci. USA 101:6641-6646.CrossRefPubMedGoogle Scholar
  9. 9.
    Buchholz, U. J. , Bukreyev, A. , Yang, L. , et al. , 2004, Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity, Proc. Natl. Acad. Sci. USA 101:9804-9809.CrossRefPubMedGoogle Scholar
  10. 10.
    Gao, W. , Tamin, A. , Soloff, A. , et al. , 2003, Effects of a SARS-associated coronavirus vaccine in monkeys, Lancet 362:1895-1896.CrossRefPubMedGoogle Scholar
  11. 11.
    Kim, T. W. , Lee, J. H. , Hung, C. F. , et al. , 2004, Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus, J. Virol. 78:4638-4645.CrossRefPubMedGoogle Scholar
  12. 12.
    Subbarao, K. , McAuliffe, J. , Vogel, L. , Fahle, G. , Fischer, S. , Tatti, K. , Packard, M. , Shieh, W. J. , Zaki, S. , and Murphy, B. , 2004, Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice, J. Virol. 78:3572-3577.CrossRefPubMedGoogle Scholar
  13. 13.
    Zhao, P. , Cao, J. , Zhao, L. J. , Qin, Z. L. , Ke, J. S. , Pan, W. , Ren, H. , Yu, J. G. , and Qi, Z. T. , 2005, Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine, Virology 331:128-135.CrossRefPubMedGoogle Scholar
  14. 14.
    Vennema, H. , Godeke, G. J. , Rossen, J. W. , Voorhout, W. F. , Horzinek, M. C. , Opstelten, D. J. , and Rottier, P. J. , 1996, Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes, EMBO J. 15:2020-2028.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  • Koji Ishii
    • 1
  • Hideki Hasegawa
    • 2
  • Noriyo Nagata
    • 3
  • Tetsuya Mizutani
    • 4
  • Shigeru Morikawa
    • 5
  • Masato Tashiro
    • 6
  • Tetsuro Suzuki
    • 7
  • Fumihiro Taguchi
    • 8
  • Toshitada Takemori
    • 9
  • Tatsuo Miyamura
    • 10
  • Yasuko Tsunetsugu-Yokota
    • 11
  1. 1.National Institute of Infectious DiseasesJapan
  2. 2.National Institute of Infectious DiseasesJapan
  3. 3.National Institute of Infectious DiseasesJapan
  4. 4.National Institute of Infectious DiseasesJapan
  5. 5.National Institute of Infectious DiseasesJapan
  6. 6.National Institute of Infectious DiseasesJapan
  7. 7.National Institute of Infectious DiseasesJapan
  8. 8.National Institute of Infectious DiseasesJapan
  9. 9.National Institute of Infectious DiseasesJapan
  10. 10.National Institute of Infectious DiseasesJapan
  11. 11.National Institute of Infectious DiseasesJapan

Personalised recommendations